Hello, Welcome to Shine Consultant !
Summit & Event Shine Speaker Bureau Shine Advisor Shine Event Service
  • Summit & Event :
    With field research of markets and industries which is analyzed from a global strategic perspective by our professional teams, as well as hot topics which interest leadership and management, Shine Consultant provides you with one-stop platform of dialogue, practice -sharing and social network!
  • Shine Speaker Bureau:
    Committed to provide keynote speakers, executive learning masterclasses and boardroom advisory for global enterprises and institutions, each service provides a deeper and more interactive experience, especially for small, selected audiences and key individuals. We have the resources of the most influential business leaders and experts, who are the most outstanding representatives in their fields. Our team consists of experienced speech and event managers, and we focus on building long-term and in-depth partnerships.
  • Shine Advisor:
    As world-class insight network, we connects clients-decision makers with vetted subject matter experts-advisors. Our clients leverage the insights and perspectives shared by our advisors to stay informed and make better business decisions.We have over 600,000 Shine Advisors in 20 industries, which continues to grow every day.
  • Shine Event Service:
    Committed to be the world's most professional provider of industrial Summit & Event. We provide one-stop professional services, including investigating and planning, on-demand inviting, marketing and promoting, operating, project management, live& digital conference, each service is performed by an experienced professional team matched with long-term industrial resources. We focus on establishing long-term and in-depth partnerships.
Guest Information
发布时间: 2019 - 09 - 24
点击次数: 0
Positions: Head of M&A and Business Development
Company: SOTIO
个人简介:
Dr. Norbert Prenzel is Head of Business Development and Licensing at SOTIO. In his role he is seeking partnership opportunities for SOTIO’s innovative oncology pipeline including in-licensing, co-development and investments.Previously Norbert was Licensing Director at Amgen where he was responsible for Amgen’s business development interactions with life science investors and Biotech and Pharma companies in Europe.He joined Amgen through the acquisition of MicrometInc., where he acted as Director Business Development overseeing BD and alliance management activities around new and existing BiTE antibody collaborations. Prior to joining Micromet, Dr. Prenzel worked as BD and Licensing Consultantfor various European Biotech companies at Staatz Business Development & Strategy. Dr. Prenzel was co-founder of U3 Pharma AG where he served as Program Director and Business Development Manager. He managed the BD activities that finally led to the acquisition of U3 Pharma by Daiichi Sankyo in 2008. Dr. Prenzel did his PhDi n Axel Ullrich’s department at the Max-Planck Institute for Biochemistry in Martinsried. In addition, he received an MBA degree from WHU/Kellogg School of Management. For his doctoral thesis on signal transduction and cancer he was awarded the Junior Research Award of the Max Planck Society.
发布时间: 2019 - 09 - 24
点击次数: 0
Positions: Ph.D.
Company: Zih-Yuan Tang Bio. Co.Ltd.
个人简介:
Expertise in Biochemistry, Molecular Microbiology, and BioengineeringExperience in Genomic Editing in mammalian and bacteriumExperience in Special chemicals by genetic modified bacterial systemDr. Lin jointed Zih Yuan Tang Biotechnology Co., Ltd in 2018 is for strategies of development andin charge of pilot-studying GYT-088 for curing diabetic retinopathy in primate model.
发布时间: 2019 - 09 - 24
点击次数: 0
Positions: CEO
Company: bBHC-STRI
个人简介:
bBHC is life science company. We world’s first developed pluripotent stem cells without side effects which is called nEPS. Also we successfully differentiated nEPS into human pancreatic beta cell, hepatocyte, neurocyte, chondrocyte, osteoblast, kidney cell and T-cell.bBHC is corporation to develop human tissues and organs.
发布时间: 2019 - 09 - 24
点击次数: 0
Positions: CEO
Company: Bionetix Inc.
个人简介:
Dr. Doo Young Jung is a founder and CEO of Bionetix, Inc. Dr. Jung has founded Bionetix, Inc. in February 2017. After receiving his Ph. D. degree in organic chemistry, Dr. Jung has developed good skills of intellectual property and business development for biotech industry. Dr. Jung had worked as a former patent examiner at Korea Intellectual Property Office from 2010 to 2012 and had been the Business Development head at Korea Research Institute of Chemical Technology, a Korean government funded research institute from 2013, where he had successfully participated in several out-licensing deals with global pharmas and biotechs. In February 2017, he has teamed up with Dr. Jin-Soo Lee, CTO of Bionetix and a former head of R&D at Dongwha Pharmaceutical Company of Korea, and with Dr. Hyunyong Cho, COO of Bionetix, and a former VP at Heraeus Korea to found Bionetix, Inc.
44页次11/11首页Previous...  234567891011Next尾页